Ep8: Pioneering a Paradigm Shift in Surgery, with Proprio and DCVC
Have you ever wondered how surgery might change in the future? In this episode, we delve into the captivating world of surgical innovation as we uncover the transformative technology developed by Proprio, a company at the forefront of surgical advancement.
Join Henry as he speaks with CEO and co-founder of Proprio, Gabriel Jones, who provides valuable insights into how the company is reshaping the landscape of surgery, promising enhanced patient outcomes and surgical precision like never before. You’ll also hear from Alan Cohen, general partner at DCVC and the lead investor in Proprio who highlights what sets Proprio apart in the realm of medical technology and why it’s poised for remarkable success.
Get a sneak peek into the future of surgery, where data, intelligence, and cutting-edge technology intersect. If you’re curious about the next frontiers in surgical innovation, this episode is a must-listen.
Topics include:
- Challenges securing funding in the current health tech environment
- The importance of enterprise technology and deep tech in the health tech sector
- Proprio’s strategy in the spine industry, aiming to become the dominant navigation platform for all surgeries
- Alan’s insights on investing in companies capturing significant value in large markets
- The importance of attracting investors with a long-term vision and diverse backgrounds
- Insights on companies that thrive during tough economic times
And more!
Key moments:
- 00:39 – Alan introduces himself and DCVC as a deep tech venture capital firm.
- 02:35 – Gabriel introduces himself and Proprio, emphasizing the paradigm shift Proprio aims to achieve in the field of surgery.
- 14:16 – Alan shares insights on identifying visionary startups and the importance of having a diverse team and data strategy.
- 20:00 – Gabriel emphasizes the importance of designing products with a user-centric approach, similar to Steve Jobs’ attention to user experience.
- 30:45 – Gabriel announces the successful closure of a 43 million Series B financing round.
- 34:00 – Alan reflects on the challenging fundraising environment in the Medtech and health tech space over the last 18 months and how it has impacted various companies.
Guest links and resources:
Connect with Henry: Twitter | LinkedIn
Connect with LSI:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Connect with Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
